AGP Executive Report
Last update: 10 hours agoCBD Research: A clinical review assesses cannabidiol’s potential benefits, molecular targets, drug interactions and commercial safety risks, as clinicians face growing patient interest in over-the-counter products. Trait Biosciences also reported greater CBD82S metabolic stability in a human liver model. Hemp Rules: A federal hemp-definition change taking effect Dec. 11 could force Wisconsin businesses to pull products containing THC, including some CBD blends. Texas governor-elect Gina Hinojosa, meanwhile, says she plans to reverse the state’s ban on hemp-derived THC sales to people under 21. Product Safety: Reports of pesticide-detection equipment failing at cannabis labs and persistent Massachusetts testing problems renew questions about the reliability of product safeguards. Medical Cannabis Access: Georgia has begun mail delivery for medical cannabis, even as USPS says the products cannot be mailed under current rules and is weighing a possible policy change tied to rescheduling.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.